Medical Device Deals Update, May 2016
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced March-April 2016.
You may also be interested in...
On Target Laboratories’ Cytalux (pafolacianine) is now approved for adult patients with ovarian cancer as an adjunct for intraoperative identification of malignant lesions.
The company’s lead candidate, AP1189, has shown promise in a mid-stage rheumatoid arthritis study, sparking plans for an imminent strategic business collaboration.
Owlet Baby Care has stopped selling its Smart Sock baby monitoring device after a five-year fight with the US Food and Drug Administration over whether the product should be regulated as a medical device. The company is now seeking FDA clearance.